Hemodialysis.com

Author Interview: Ana Maria Merino MD

Losartan prevents the development of the pro-inflammatory monocytes CD14+CD16+ in hemodialysis patients


Ana Merino, Maria Antonia Alvarez-Lara, Rafael Ramirez, 
Julia Carracedo,Alejandro Martin-Malo, and Pedro Aljama

Nephrol. Dial. Transplant. first published online January 13, 2012 doi:10.1093/ndt/gfr767

Author Interview: Rosilene Motta Elias

When Is the Best Moment to Assess the Ankle Brachial Index: Pre- or Post-Hemodialysis?

Zaida Noemy Cabrera Jimenez, Isac de Castro, Benedito Jorge Pereira,
Rodrigo Bueno de Oliveira,João Egidio Romão, Jr., Rosilene Motta Elias
Renal Division, Internal Medicine, Hospital das Clínicas,
University of São Paulo School of Medicine, São Paulo, Brazil
Kidney and Blood Pressure ResearchVol. 35, No. 4, 2012

ASN Press Release 2011
HIGH BLOOD PRESSURE AND PREGNANCY: SHORT- AND LONG-TERM CONSEQUENCES
Mid-pregnancy test predicts late-pregnancy complication
High blood pressure during pregnancy spells trouble later in life

Author Interview: Donald E. Wesson, M.D
Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy

Nimrit Goraya, Jan Simoni, Chanhee Jo and Donald E Wesson
Kidney Int advance online publication, August 31, 2011; doi:10.1038/ki.2011.313

Author Interview: Steven M. Brunelli

A Model of Systolic Blood Pressure During the Course of Dialysis and Clinical Factors Associated With Various Blood Pressure Behaviors

Published online: 02 August 2011
Kumar Dinesh, Srikanth Kunaparaju, Kathryn Cape, Jennifer E. Flythe, Harold I. Feldman, Steven M. Brunelli
DOI: 10.1053/j.ajkd.2011.05.028
American Journal of Kidney Diseases 

Author Interview: Tara I Chang, MD, MS
Systolic Blood Pressure and Mortality in Patients on Hemodialysis.

Chang TI.
Curr Hypertens Rep. 2011 Jul 30.

Author Interview: James B. Wetmore, MD
Geographic Variation in Cardioprotective Antihypertensive Medication Usage in Dialysis Patients

American Journal of Kidney Diseases - 30 May 2011 (10.1053/j.ajkd.2011.02.387)
James B. Wetmore, MD , Jonathan D. Mahnken, PhD , Purna Mukhopadhyay, Ph , Qingjiang Hou, MS Edward F. Ellerbeck, MD, MPH , Sally K. Rigler, MD, MPH ,  John A. Spertus, MD, MPH ,
Theresa I. Shireman, PhD, RPh

HERCULES Trial Demonstrates Significant Reduction In Systolic Blood Pressure While Revealing Marker In Hypertensive Patients Does Not Predict

BNP Level Prior to Stenting Did Not Predict Blood Pressure Outcomes After Stenting
BALTIMORE (May 5, 2011) – A substance secreted by the heart that is associated with congestive heart failure and renal failure is not predictive of reduction in systolic blood pressure in patients treated with renal artery stenting, according to results from the HERCULES trial presented as a Late-Breaking Clinical Trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions.

Blasting kidney nerves with radio waves helps lower blood pressure for those with stubborn hypertension

American Heart Association Press Release Abstract 21826
Study highlights: 

• A procedure to deactivate nerves around the kidney arteries substantially reduces blood pressure in patients whose hypertension is not adequately reduced by medications, according to a new study.

• The treatment shows promise for hypertensive patients whose high blood pressure isn’t lowered enough by currently available treatments, which is the case for about one in five people with hypertension.

Hemodialysis.com Editor's Note: Hypentension, especially uncontrolled hypertension, is a leading cause of kidney failure leading to the need for hemodialysis or dialysis.

Renovascular Hypertension and Ischemic Nephropathy.

Am J Hypertens. 2010 Sep 23.

Textor SC, Lerman L.
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.

Intensive blood-pressure control in hypertensive chronic kidney disease.

N Engl J Med. 2010 Sep 2;363(10):918-29.

AASK Collaborative Research Group.
Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD 21205-2223, USA.

Blood pressure management in hemodialysis: what have we learned?

Curr Opin Nephrol Hypertens.
2010 Sep 8.

Peixoto AJ,  Santos SF.
Medical Service, VA Connecticut Healthcare System, West Haven, USA; Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut, USA ; Division of Nephrology, State University of Rio de Janeiro (UERJ), Rio de Janeiro, Rio de Janeiro, Brazil.

Should All Hypertensive Dialysis Patients Receive a Blocker of the Renin-Angiotensin System?

Curr Hypertens Rep. 2010 Sep 7.

Sinha AD, Agarwal R.
Veterans Affairs Medical Center, 111N, 1481 West 10th Street, Indianapolis, IN, 46202

Hypertension in end-stage renal disease: different measures and their prognostic significance.

Nephrol Dial Transplant. 2010 Aug 4.
Hörl WH.
Division of Nephrology and Dialysis, Department of Medicine III, University of Vienna, Vienna, Austria.

Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference.

Kidney Int. 2010 Feb;77(4):273-84.

Levin NW, et al
Renal Research Institute, New York 10128, USA.

Blood pressure and mortality among hemodialysis patients.
Hypertension. 2010 Mar;55(3):762-8.
Agarwal R.

Acute Kidney Injury and Cardiovascular Outcomes in Acute Severe Hypertension
(Circulation. 2010;121:2183-2191.)